ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Technology Enabled And Molecular Monitoring Of The Allograft And Transplant Recipient Study

N. Sulejmani1, D. Axelrod2, S. Dholakia1, S. Shah3

1CareDx, South San Francisco, CA, 2University of Iowa, Iowa City, IA, 3University of Cincinnati, Cincinnati, OH

Meeting: 2022 American Transplant Congress

Abstract number: 9043

Keywords: Monitoring, Multicenter studies, Post-transplant hypertension, Rejection

Topic: Basic & Clinical Science » Basic & Clinical Science » 74 - Clinical Trials

Session Information

Session Name: Clinical Trials

Session Type: Poster Abstract

Date: Saturday, June 4, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-7:00pm

Location: Hynes Halls C & D

*Purpose: With the widespread availability of smart mobile devices, mobile health (mHealth) provides the opportunity to reach wide array of patients. Readmission rates as high as 45% have been reported amongst solid organ transplant (SOT) recipients and can be clinically and financially detrimental. Many readmissions can be prevented through utilization of novel technology to deliver post-transplant (PT) care in a patient centric manner. Pilot studies have demonstrated technology enabled patient monitoring leads to reduction in readmissions through early recognition and outpatient intervention. Here, we describe a large study utilizing AlloCare application for remote patient monitoring and its impact on SOT readmission rates.

*Methods: Technology Enabled And Molecular Monitoring of the Allograft and Transplant Recipient (TEAMMATE, NCT05033548) study is a prospective, multi-center, randomized, control study of 4,000 kidney, liver, heart, and lung transplant recipients. Patients will be randomized 1:1 in either AlloCare or standard of care arm. The primary objective of the study is all-cause reduction in readmission rates within 90 days PT. Secondary endpoints include biopsy-proven acute rejection, medication adherence, blood pressure and diabetes control within the first year and patient SF-36 scores at 90 days. Patients randomized to AlloCare arm will submit a summary statistics report of the health metrics monitored on a weekly basis for 90 days PT then monthly until 12 months PT.

*Results: Total of 6 sites have been activated thus far with the first patient enrolled in the study on November 16, 2021. There are currently 9 patients enrolled in the study. We anticipate nearly 100 sites to participate with the number of patients enrolled significantly increased in 2022.

*Conclusions: Role of mHealth has increased significantly in the last decade. With TEAMMATE being the largest prospective, multi-center, randomized, control study utilizing mHealth in SOT will demonstrate the impact of remote patient monitoring utilizing AlloCare on readmission rates.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Sulejmani N, Axelrod D, Dholakia S, Shah S. Technology Enabled And Molecular Monitoring Of The Allograft And Transplant Recipient Study [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/technology-enabled-and-molecular-monitoring-of-the-allograft-and-transplant-recipient-study/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences